Patients with types I and II diabetes should watch for hypoglycemia (low blood sugar) when they begin taking the TreolifeVM and TreolifeEFA formulas due to an anticipated drop in their blood glucose levels (as a result of anticipated increase in insulin sensitivity or decrease in insulin resistance). Patients using these formulas should consult their physician to ensure insulin dosages or oral hypoglycemic medications are appropriately adjusted (decreased), especially if combined with a decrease in their carbohydrate consumption and/or an increase in their activity levels.

Caution for people taking the Treolife EFA formula:

If you are pregnant/nursing, taking any medications, or planning a medical or dental procedure, please contact your heath-care practitioner before using. Do not use if you are taking any blood thinner, medication or have sensitivity to any of this supplement's ingredients.